معرفی
Niklas Loman is an Associate Professor and Principal Investigator at the Lund University Cancer Centre (LUCC), affiliated with Lund University. His primary roles include Consultant, Project Manager, and Supervisor in breast/ovarian cancer research.
Research Focus: Loman’s work centers on breast and ovarian cancer, particularly BRCA1/2 mutations, genetic testing, immunometabolism dynamics, and clinical trial design. His contributions include the Sweden Cancerome Analysis Network-Breast (SCAN-B) initiative, a large-scale genomic analysis platform, and the NordicTrip phase III trial exploring chemotherapy combinations for triple-negative breast cancer.
Publications & Projects: With 127 publications, his recent work includes studies on estrogen receptor-low breast cancers, longitudinal immunometabolic profiling, and genetic testing guidelines. Active projects include NordicTrip (2024–2029) and SCAN-B (since 2009), focusing on genomic insights and clinical implementation.
Awards & Recognition: While no specific awards are listed, his contributions to breast cancer genomics and clinical trials reflect significant academic impact.
Grants & Teams: Funded by Cancerfonden and Mrs. Berta Kamprad’s Cancer Foundation, Loman collaborates on translational research and organizes events like the LUCC Breast Retreat and seminars on HER2-positive/triple-negative cancers.
